Lymphocyte-predominant Hodgkin lymphoma: Patient outcomes from a large single-institution series with long follow-up

被引：0
|
作者：
Chen, R. C. [1 ]
Chin, M. S. [2 ]
Ng, A. K. [3 ]
Silver, B. [3 ]
Mauch, P. M. [3 ]
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [41] Excellent Long-term Outcomes in Patients With Early Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated With Radiation Therapy
    Solanki, A. A.
    LeMieux, M. H.
    Mahmood, U.
    Hasan, Y.
    Koshy, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S60 - S61
  • [42] Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis
    Gerber, Naamit K.
    Atoria, Coral L.
    Elkin, Elena B.
    Yahalom, Joachim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 76 - 83
  • [43] Diffuse large B-cell lymphoma: A single-institution experience of patient outcomes
    Chan, Ryan James
    Gupta, Rasna
    Kanjeekal, Sindu Mary
    Jarrar, Mohammed
    Kay, Amin
    Mathews, John
    Woldie, Indryas Lemma
    Hamm, Caroline M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [44] A retrospective cohort of lymphocyte-predominant Hodgkin lymphoma: A long-term outcome and the risk of transformation into diffuse large-B cell lymphoma
    Biasoli, I.
    Stamatoullas, A.
    Divine, M.
    Salles, G.
    Voillat, L.
    Reman, O.
    Morschhauser, F.
    Audouin, J.
    Brice, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 112 - 112
  • [45] EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience
    Fei, Fei
    Kiruthiga, Kala Gnanasekaran
    Younes, Sheren
    Natkunam, Yasodha
    HUMAN PATHOLOGY, 2022, 129 : 32 - 39
  • [46] Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
    Thalambedu, Nishanth
    Chen, Zhongning
    Vellanki, Sruthi
    Kumar, Anup Kumar Trikannad Ashwini
    Varma, Ankur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S451 - S451
  • [47] Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group
    Marks, Lianna J.
    Pei, Qinglin
    Bush, Rizvan
    Buxton, Allen
    Appel, Burton
    Kelly, Kara M.
    Schwartz, Cindy L.
    Friedman, Debra L.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
  • [48] Successful treatment of a patient with lymphocyte-predominant Hodgkin's lymphoma with yttrium-90-ibritumomab tiuxetan
    Zojer, Niklas
    Mirzaei, Siroos
    Ludwig, Heinz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (04) : 322 - 324
  • [49] Clonal identification of Burkitt's lymphoma arising from lymphocyte-predominant Hodgkin's disease
    Yoshinaga, H
    Ohashi, K
    Yamamoto, K
    Miki, T
    Miura, O
    Saito, T
    Koyama, T
    Kanazawa, A
    Nemoto, T
    Miyasaka, N
    Kamiyama, R
    Hirosawa, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (02) : 380 - 382
  • [50] Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution
    Petit, J. Y.
    Gentilini, O.
    Rotmensz, N.
    Rey, P.
    Rietjens, M.
    Garusi, C.
    Botteri, E.
    De Lorenzi, F.
    Martella, S.
    Bosco, R.
    Khuthaila, D. K.
    Luini, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (03) : 545 - 549
12345